VANCOUVER, British Columbia--(BUSINESS WIRE)--Contextual Genomics, a molecular diagnostics company developing genomic based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based medicine to Canadians, are pleased to welcome Pfizer Canada to its National Access Project consortium.
The National Access Project’s aim is to make genomic cancer testing available to any Canadian diagnosed with cancer and to drive and facilitate a shift toward personalized medicine, in which patients receive tailored treatment options correlated to their specific tumor profile. Pfizer Canada has provided a grant and technical support as part of their commitment to the National Access Project for Cancer Testing.
Help employers find you! Check out all the jobs and post your resume.